questionsmedicales.fr
Maladies du système stomatognathique
Maladies de la bouche
Maladies parodontales
Atrophie parodontale
Atrophie parodontale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Atrophie parodontale : Questions médicales les plus fréquentes",
"headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies parodontales",
"url": "https://questionsmedicales.fr/mesh/D010510",
"about": {
"@type": "MedicalCondition",
"name": "Maladies parodontales",
"code": {
"@type": "MedicalCode",
"code": "D010510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Résorption alvéolaire",
"alternateName": "Alveolar Bone Loss",
"url": "https://questionsmedicales.fr/mesh/D016301",
"about": {
"@type": "MedicalCondition",
"name": "Résorption alvéolaire",
"code": {
"@type": "MedicalCode",
"code": "D016301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Récession gingivale",
"alternateName": "Gingival Recession",
"url": "https://questionsmedicales.fr/mesh/D005889",
"about": {
"@type": "MedicalCondition",
"name": "Récession gingivale",
"code": {
"@type": "MedicalCode",
"code": "D005889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perte d'attache parodontale",
"alternateName": "Periodontal Attachment Loss",
"url": "https://questionsmedicales.fr/mesh/D017622",
"about": {
"@type": "MedicalCondition",
"name": "Perte d'attache parodontale",
"code": {
"@type": "MedicalCode",
"code": "D017622",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465.714.354.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Atrophie parodontale",
"alternateName": "Periodontal Atrophy",
"code": {
"@type": "MedicalCode",
"code": "D055093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Frederik Barkhof",
"url": "https://questionsmedicales.fr/author/Frederik%20Barkhof",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden."
}
},
{
"@type": "Person",
"name": "Maria Teresa Pellecchia",
"url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy."
}
},
{
"@type": "Person",
"name": "Iva Stankovic",
"url": "https://questionsmedicales.fr/author/Iva%20Stankovic",
"affiliation": {
"@type": "Organization",
"name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia."
}
},
{
"@type": "Person",
"name": "Gregor K Wenning",
"url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
},
{
"@type": "Person",
"name": "Klaus Seppi",
"url": "https://questionsmedicales.fr/author/Klaus%20Seppi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Benign prostatic hyperplasia associated with white matter hyperintensities in men.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37116223",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clineuro.2023.107738"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36769190",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24032870"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer.",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36685547",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.998447"
}
},
{
"@type": "ScholarlyArticle",
"name": "The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35634569",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/CIA.S365282"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.",
"datePublished": "2023-08-01",
"url": "https://questionsmedicales.fr/article/37642075",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2023.24.8.2861"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la bouche",
"item": "https://questionsmedicales.fr/mesh/D009059"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies parodontales",
"item": "https://questionsmedicales.fr/mesh/D010510"
},
{
"@type": "ListItem",
"position": 5,
"name": "Atrophie parodontale",
"item": "https://questionsmedicales.fr/mesh/D055093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Atrophie parodontale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Atrophie parodontale",
"description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Atrophie parodontale",
"description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Atrophie parodontale",
"description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Atrophie parodontale",
"description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Atrophie parodontale",
"description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Atrophie parodontale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Prostatic+Hyperplasia&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'atrophie parodontale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'atrophie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'atrophie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent la récession gingivale et la mobilité dentaire."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale est-elle réversible ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'atrophie parodontale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives qui saignent ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'atrophie parodontale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le brossage des dents ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les produits de rinçage buccal sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la santé parodontale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives."
}
},
{
"@type": "Question",
"name": "Fumer affecte-t-il la santé parodontale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'atrophie parodontale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utilisés dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales."
}
},
{
"@type": "Question",
"name": "Comment la thérapie au laser aide-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils douloureux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'atrophie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'atrophie parodontale peut-elle affecter la santé générale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Comment l'atrophie affecte-t-elle la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi."
}
},
{
"@type": "Question",
"name": "Les infections parodontales peuvent-elles se propager ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'atrophie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé parodontale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale."
}
},
{
"@type": "Question",
"name": "Une alimentation déséquilibrée influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie."
}
}
]
}
]
}
Benign prostatic hyperplasia (BPH) describes common noncancerous prostate enlargement. BPH is usually associated with lower urinary tract symptoms and an increased risk of cerebrovascular diseases, su...
A total of 788 male patients from the First Affiliated Hospital of Kunming Medical University from July 2019 to September 2021 were enrolled in this cross-sectional study. BPH was assessed by abdomina...
Patients with BPH presented an increased risk of WMHs with a crude odds ratio (OR) of 2.76 (95% CI, 2.02-3.79) and an adjusted OR of 1.75 (95% CI, 1.24-2.48) after controlling for potential confoundin...
We found that BPH was closely associated with WMHs in male Chinese individuals....
Benign prostatic hyperplasia (BPH) is a common disease in elderly men. It is characterized by prostatic enlargement and urethral compression and often causes lower urinary tract symptoms (LUTs) such a...
Noninvasive methods for the early identify diagnosis of prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer (PCa) are current clinical challenges....
The serum metabolites of 20 healthy individuals and patients with prostatitis, BPH, or PCa were identified using untargeted liquid chromatography-mass spectrometry (LC-MS). In addition, targeted LC-MS...
Organic acid metabolites had good sensitivity and specificity in differentiating prostatitis, BPH, and PCa. Three diagnostic models identified patients with PROSTATITIS: phenyllactic acid (area under ...
Transurethral resection of the prostate (TURP) is often indicated for benign prostatic hyperplasia (BPH). Some patients, however, fail to adequately respond to these interventions. Accordingly, a powe...
Clinical data from 356 BPH subjects who underwent TURP were retrospectively collected between November 2015 and June 2021 for nomogram development. The prediction model was developed using multivariab...
In multivariate analysis of the primary cohort, the independent factors for TURP efficacy were age, International Prostate Symptom Score (IPSS), intravesical prostatic protrusion (IPP), bladder wall t...
The P.R.OS.T.A.T.E nomogram objectively and accurately predicted TURP efficacy, thereby facilitating the clinical decision-making process....
This observational comparative study aimed at investigating the diagnostic accuracy of ERG in differentiating benign and malignant prostatic lesions and comparing it to the diagnostic accuracy of AMAC...
Seventy- two cases (22 prostatic hyperplasia and 50 prostatic carcinoma) were collected from the pathology department at Cairo university. The cases were immunostained by antibodies against AMACR and ...
AMACR showed 62% sensitivity and 86.4% specificity for the diagnosis of PC, with a statistically significant differential expression in benign and malignant lesions (P=0.001). Its expression also corr...
Although ERG proved no superior value than AMACR in diagnosing prostatic lesions, combining both markers may lead to higher diagnostic accuracy owing to higher ERG specificity for PC....
Prostate cancer (PCA) is one of the leading causes of death among men, being related to several factors, including the aging male population, like benign prostatic hyperplasia (BPH), a histopathologic...
348 samples were analyzed, being 123 from PCA patients, 143 BPH patients and 82 healthy controls, using PCR-RFLP techniques. The results of genotyping analysis were adjusted by age, and compared with ...
Our data indicate the FASLCC genotype as a risk factor for prostate pathologies, whileBCL-2 CC can act as a protective genotype....
To observe the efficacy and safety of transurethral columnar balloon dilation of the prostate (TUCBDP) for benign prostatic hyperplasia (BPH) in a multicenter trial....
This multicenter study included 2050 patients with BPH who underwent TUCBDP from 11 cities of Zhejiang Province, from September 2015 to June 2021. Clinical assessment included recording and measuremen...
One month after surgery, the patients' IPSS score, QoL, and PVR were significantly decreased, while the Qmax, IIEF-5, and MSHQ-EjD-SF scores were increased considerably, compared with preoperative dat...
Collectively, TUCBDP may effectively improve the urinary and sexual function of BPH patients, with fewer postoperative complications, and its efficacy is not limited by age and prostate volume. It can...
As men age, a growing number develop benign prostatic hyperplasia (BPH). According to previous research, diabetes may be a risk factor. Pyruvate dehydrogenase kinase 4 (PDK4) is closely related to glu...
With an increasing reliance on online sources for medical information, we studied the quality and completeness of health literacy videos on TikTok regarding BPH....
A cross-sectional systematic evaluation of TikTok videos using the search term "Benign Prostatic Hyperplasia" was performed on 14th April 2023, and included 49 patient information and educational vide...
Of the 49 videos, 38 were created by healthcare professionals (HCPs). The average length of each video was 62.7 ± 59.3 s, with a large average number of total views (24,990.1 ± 109,534.9 views). The D...
BPH videos on TikTok have a wide reach, but the videos are mostly of low quality and completeness. Future videos should be made with quality and completeness in mind given the large viewership and mor...
Prostate hyperplasia and cancer are more prevalent in middle-aged and elderly men. Previous studies have linked both disorders to androgen receptors. Herein, efforts were made to identify factors asso...
An analytical framework was established utilizing the "Prostate Cancer Early Warning Dataset" from the National Clinical Medical Science Data Center. Variables selection was conducted through LASSO re...
A total of 1,502 patients with BPH and 294 with combined PCa were hereby included. Multivariate regression delineated several independent predictors of PCa coexistence, including age (OR [95% CI]: 1.0...
The analysis revealed connections between PCa occurrence in men aged over 60 and BPH, along with specific serum biomarkers such as inorganic phosphorus, globulin, LDL cholesterol, lower fPSA/tPSA rati...